Evidence map›Paper›PMID 24012919›Full record

ArticleFree radical biology & medicine2013

Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling.

Elizabeth D Moore, Mitra Kooshki, Linda J Metheny-Barlow, Patricia E Gallagher, Mike E Robbins

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 57 citations in OpenAlex.

  1. Radiomitigators: Breakthroughs in Post-Radiation Recovery.Antioxidants (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Targets for protection and mitigation of radiation injury.Cellular and molecular life sciences : CMLS · 2020
    Review
  16. Article
  17. Article
  18. Renin-Angiotensin System Inhibitors to Mitigate Cancer Treatment-Related Adverse Events.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Review
  19. Article
  20. Macrophages in neuroinflammation: role of the renin-angiotensin-system.Pflugers Archiv : European journal of physiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Elizabeth D MooreDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. Electronic address: elmoore2@wakehealth.edu.
Mitra KooshkiDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Linda J Metheny-BarlowDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Patricia E GallagherHypertension and Vascular Research Center, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Mike E RobbinsDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Wake Forest University · US

Funding

PPARs and Radiation-induced Brain InjuryR01CA112593 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BLACKSTOCK, ARTHUR W, METHENY-BARLOW, LINDA J · 2004 to 2013
$3.0M
The Renin-Angiotensin System, Inflammation and Radiation-induced Brain InjuryR01CA122318 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ROBBINS, MICHAEL E. · 2006 to 2010
$1.2M
NCI NIH HHS CA112593NCI NIH HHS CA122318NCI NIH HHS R01 CA112593NCI NIH HHS R01 CA122318
6 · The paper itself

Abstract

About 500,000 new cancer patients will develop brain metastases in 2013. The primary treatment modality for these patients is partial or whole brain irradiation which leads to a progressive, irreversible cognitive impairment. Although the exact mechanisms behind this radiation-induced brain injury are unknown, neuroinflammation in glial populations is hypothesized to play a role. Blockers of the renin-angiotensin system (RAS) prevent radiation-induced cognitive impairment and modulate radiation-induced neuroinflammation. Recent studies suggest that RAS blockers may reduce inflammation by increasing endogenous concentrations of the anti-inflammatory heptapeptide angiotensin-(1-7) [Ang-(1-7)]. Ang-(1-7) binds to the AT(1-7) receptor and inhibits MAP kinase activity to prevent inflammation. This study describes the inflammatory response to radiation in astrocytes characterized by radiation-induced increases in (i) IL-1β and IL-6 gene expression; (ii) COX-2 and GFAP immunoreactivity; (iii) activation of AP-1 and NF-κB transcription factors; and (iv) PKCα, MEK, and ERK (MAP kinase) activation. Treatment with U-0126, a MEK inhibitor, demonstrates that this radiation-induced inflammation in astrocytes is mediated through the MAP kinase pathway. Ang-(1-7) inhibits radiation-induced inflammation, increases in PKCα, and MAP kinase pathway activation (phosphorylation of MEK and ERK). Additionally Ang-(1-7) treatment leads to an increase in dual specificity phosphatase 1 (DUSP1). Furthermore, treatment with sodium vanadate (Na3VO4), a phosphatase inhibitor, blocks Ang-(1-7) inhibition of radiation-induced inflammation and MAP kinase activation, suggesting that Ang-(1-7) alters phosphatase activity to inhibit radiation-induced inflammation. These data suggest that RAS blockers inhibit radiation-induced inflammation and prevent radiation-induced cognitive impairment not only by reducing Ang II but also by increasing Ang-(1-7) levels.

Indexed as

MAP Kinase Signaling SystemAngiotensin IAnimalsAstrocytesCells, CulturedDrug Evaluation, PreclinicalDual Specificity Phosphatase 1InflammationPeptide FragmentsPrimary Cell CultureRadiation-Protective AgentsRatsAngiotensin Iangiotensin I (1-7)Dual Specificity Phosphatase 1Dusp1 protein, ratPeptide FragmentsRadiation-Protective AgentsACEIAngAngiotensinAngiotensin-(1–7)Angiotensin converting enzyme inhibitorAngiotensin receptor blockerARBCOX-2Cyclooxygenase-2Dual specificity phosphatase 1DUSP1Electromobility-shift assayEMSAERKExtracellular signal-regulated kinaseFractionated whole brain irradiationfWBIGFAPGlial fibrillary acidic proteinILInterleukinMAP kinase signalingMEKMitogen-activated protein erk kinaseRadiation-induced InflammationRASRat primary astrocytesRenin-angiotensin systemTNF-αTumor necrosis factor-α

Identifiers

PMID24012919
PMCPMC3879043
OpenAlexW1997213238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.